| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.13 | 0.5 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.5 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |